Vermillion Cuts Q2 Loss by 35 Percent | GenomeWeb
NEW YORK (GenomeWeb News) – Vermillion today reported a 35 percent improvement for its second-quarter net loss but no revenues for the three months ended June 30, 2008.
 
The company’s net loss shrank to $4.5 million, or $.70 per share, from $6.8 million, or $1.74 per share, in the second quarter of 2007.
 
Earnings-per-share calculations for both years account for the 10-for-one reverse stock split that the company enacted in March.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Ivanka Trump and Secretary of Education Betsy DeVos call on girls to pursue STEM careers, the Associated Press reports.

Some science companies will be taking part in next month's March for Science, Fortune reports.

In Genome Research this week: longitudinal study of Burkholderia cenocepacia isolates from cystic fibrosis patients, long-read assembly approach, and more.

Shale oil companies are turning to DNA sequencing to find spots to drill, Reuters reports.